Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization by Staley, James & Burgess, Stephen
Received: 4 September 2016 Revised: 25 November 2016 Accepted: 4 February 2017
DOI: 10.1002/gepi.22041
RESEARCH ART ICLE
Semiparametric methods for estimation of a nonlinear
exposure-outcome relationship using instrumental variables
with application to Mendelian randomization
James R. Staley Stephen Burgess
Strangeways Research Laboratory, Depart-
ment of Public Health and Primary Care,
Cardiovascular Epidemiology Unit, University
of Cambridge, United Kingdom
Correspondence
StephenBurgess, StrangewaysResearchLab-
oratory,Department of PublicHealth andPri-
maryCare,Cardiovascular EpidemiologyUnit,
University ofCambridge,Wort’sCauseway,
CambridgeCB18RN,UK.
Email: sb452@medschl.cam.ac.uk
Grant sponsor:UKMedicalResearchCoun-
cil;Grant numbers:G66840,G0800270;
Grant sponsor: Pﬁzer;Grant number:G73632;
Grant sponsor:BritishHeart Foundation;
Grant number: SP/09/002;Grant sponsor:UK
National Institute forHealthResearchCam-
bridgeBiomedicalResearchCentre;Grant
sponsor: EuropeanResearchCouncil;Grant
number: 268834;Grant sponsor: European
CommissionFrameworkProgramme7;Grant
number:HEALTH-F2-2012-279233;Grant
sponsor:WellcomeTrust;Grant number:
100114.
ABSTRACT
Mendelian randomization, the use of genetic variants as instrumental variables (IV),
can test for and estimate the causal eﬀect of an exposure on an outcome.Most IVmeth-
ods assume that the function relating the exposure to the expected value of the out-
come (the exposure-outcome relationship) is linear. However, in practice, this assump-
tion may not hold. Indeed, often the primary question of interest is to assess the shape
of this relationship. We present two novel IV methods for investigating the shape of
the exposure-outcome relationship: a fractional polynomial method and a piecewise
linear method. We divide the population into strata using the exposure distribution,
and estimate a causal eﬀect, referred to as a localized average causal eﬀect (LACE), in
each stratum of population. The fractional polynomial method performs metaregres-
sion on these LACE estimates. The piecewise linear method estimates a continuous
piecewise linear function, the gradient of which is the LACE estimate in each stratum.
Both methods were demonstrated in a simulation study to estimate the true exposure-
outcome relationship well, particularly when the relationship was a fractional polyno-
mial (for the fractional polynomial method) or was piecewise linear (for the piecewise
linear method). The methods were used to investigate the shape of relationship of body
mass index with systolic blood pressure and diastolic blood pressure.
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1 INTRODUCTION
Often the shape of association between an exposure and an
outcome is nonlinear. For example, the observed association
between body mass index (BMI) and all-cause mortality in a
Western context is J-shaped (or U-shaped), as risk ofmortality
is increased for individuals at both ends of the BMI distribu-
tion (Flegal, Kit, Orpana, & Graubard, 2013). However, par-
ticularly for underweight individuals, this could reﬂect either
reverse causality or confounding, rather than a true causal
eﬀect of lowBMI increasingmortality risk. Instrumental vari-
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original
work is properly cited.
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able (IV) methods can be used to distinguish between correla-
tion and causation. However, these methods typically assume
that the exposure-outcome relationship is linear when estimat-
ing a causal eﬀect (Hernán & Robins, 2006). In many cases,
investigating the shape of the exposure-outcome relationship
is the primary aim of a study. This can be used to deﬁne treat-
ment thresholds for pharmaceutical interventions or health
guidelines.
A natural way of tackling the nonlinearity problem in IV
analysis is to perform a two-stage analysis similar to the
well-known two-stage least squares method, except ﬁtting a
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nonlinear function in the second stage (Horowitz, 2011;
Newey & Powell, 2003). However, this approach requires
the instrument and any covariates included in the ﬁrst-stage
model to explain a large proportion of variance in the expo-
sure, as information for assessing the shape of relationship
between the exposure and outcome will only be available for
the ﬁtted values of the exposure from the ﬁrst-stage regres-
sion. If the proportion of variance in the exposure explained
by the IV is small, then observing nonlinearity for this limited
range of values is unlikely. In Mendelian randomization, the
use of genetic variants as IV, genetic variants typically only
explain a small percentage of the variance in the exposure
(usually in the region of 1–4%; Burgess & Thompson, 2015;
Ebrahim & Smith, 2008).
Two approaches for addressing nonlinearity in the con-
text of Mendelian randomization have recently been proposed
(Burgess, Davies, & Thompson, 2014; Silverwood et al.,
2014). Burgess et al. (2014) assessed the consequences of per-
forming a linear IV analysis when the exposure-outcome rela-
tionship truly was nonlinear, as well as stratifying individ-
uals using the exposure distribution to obtain IV estimates,
referred to as localized average causal eﬀects (LACE), in
each stratum. Silverwood et al. (2014) performed metaregres-
sion of LACE estimates across strata to examine whether a
quadratic rather than a linear model was a better ﬁt for rela-
tionships between alcohol consumption and a variety of car-
diovascular markers.
In this paper, we present two novel semiparametric meth-
ods for investigating the shape of the exposure-outcome rela-
tionship using IV analysis developed for use in Mendelian
randomization. The ﬁrst is based on fractional polynomials
(Royston & Altman, 1994; Royston, Ambler, & Sauerbrei,
1999), whereas the second ﬁts a piecewise linear function.
We also propose a test for nonlinearity based on the frac-
tional polynomial method, and assess the impact of varying
the number of strata of the exposure distribution used to test
for nonlinearity and to estimate nonlinear relationships. We
illustrate the methods using data from UK Biobank (Sudlow
et al., 2015), a large UK-based cohort, to investigate the shape
of the relationship between BMI and blood pressure using
Mendelian randomization.
2 METHODS
2.1 Stratifying on the IV-free exposure
We deﬁne the exposure-outcome relationship as the function
relating the exposure to the expected value of the outcome.
We initially assume that this function is homogeneous for all
individuals in the population, and return to its interpretation
in case of heterogeneity in the discussion.
To assess the shape of association between exposure𝑋 and
outcome 𝑌 using a single instrument 𝐺, we ﬁrst stratify the
population using the exposure distribution. If we were to strat-
ify on the exposure directly, then an association between the
IV and outcome might be induced even if it were not present
in the original data, thus invalidating the IV assumptions
(Didelez & Sheehan, 2007). This problem can be avoided by
instead stratifying on the residual variation in the exposure
after conditioning on the IV, assuming that the eﬀect of the
IV on the exposure is linear and constant for all individuals
across the entire of the exposure distribution (Burgess et al.,
2014). In econometrics, this residual is known as a control
function (Arellano, 2003). We calculate this residual by per-
forming linear regression of the exposure on the IV, and then
setting the value of the IV to 0. We refer to this as the IV-free
exposure. It is the expected value of the exposure that would
be observed if the individual had an IV value of 0, and can be
interpreted as the nongenetic component of the exposure.
In each stratum of the IV-free exposure, we estimate the
LACE as a ratio of coeﬃcients: the IV association with the
outcome divided by the IV association with the exposure.
The assumption that the eﬀect of the IV on the exposure is
constant is a stronger version of the monotonicity assumption
(Angrist, Imbens, & Rubin, 1996), and hence the LACE are
local average treatment eﬀects (also called complier-averaged
causal eﬀects; Yau & Little, 2001) for each stratum (Imbens
& Angrist, 1994). We then proceed to estimate the exposure-
outcome relationship from these LACE estimates using two
approaches: the ﬁrst based on fractional polynomials, and the
second a piecewise linear function.
2.2 Fractional polynomial method
The fractional polynomial method consists of metaregres-
sion of the LACE estimates against the mean of the expo-
sure in each stratum in a ﬂexible semiparametric framework
(Bagnardi, Zambon, Quatto, & Corrao, 2004; Thompson &
Sharp, 1999). Fractional polynomials are a family of func-
tions that can be used to ﬁt complex relationships for a sin-
gle covariate (Royston & Altman, 1994). The standard pow-
ers used when modeling using fractional polynomials are 𝑃 =
{−2,−1,−0.5, 0, 0.5, 1, 2, 3}, where the power of 0 refers to
the (natural) log function. These powers are used throughout
this paper. Fractional polynomials of degree 1 are deﬁned as
𝑓 (𝑥) = 𝛽0 + 𝛽1𝑥𝑝, (1)
where 𝑝 ∈ 𝑃 . Similarly, fractional polynomials of degree 2
are deﬁned as
𝑓 (𝑥) =
{
𝛽0 + 𝛽1𝑥𝑝1 + 𝛽2𝑥𝑝2 if 𝑝1 ≠ 𝑝2
𝛽0 + 𝛽1𝑥𝑝 + 𝛽2𝑥𝑝log(𝑥) if 𝑝1 = 𝑝2 = 𝑝,
(2)
where 𝑝1, 𝑝2 ∈ 𝑃 . In both cases, 𝑥0 is interpreted as log(𝑥).
As fractional polynomials of degree larger than 2 are rarely
required in practice, these were not considered in this paper
(Royston & Altman, 1994). Because a causal eﬀect is an esti-
mate of the derivative of the exposure-outcome relationship
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(Small, 2014), we ﬁt the LACE estimates using the derivative
of the fractional polynomial function (from either (1) or (2)).
The method proceeds as follows. First, we calculate the IV-
free exposure, and stratify the population based on quantiles
of its distribution. Second, the LACE estimate is calculated in
each stratum as a ratio of coeﬃcients (the LACE estimate for
stratum 𝑘 is
𝛽𝑌 |𝐺,𝑘
𝛽𝑋|𝐺 , where 𝛽𝑌 |𝐺,𝑘 is the estimated association of
the IV with the outcome in stratum 𝑘 and 𝛽𝑋|𝐺 is the estimated
association of the IV with the exposure in the whole popula-
tion), and the standard error of the LACE estimate is com-
puted as
𝑠𝑒(𝛽𝑌 |𝐺,𝑘)
𝛽𝑋|𝐺 (the ﬁrst term of the delta method approx-
imation; Thomas, Lawlor, & Thompson, 2007). Third, these
LACE estimates are metaregressed against the mean of the
exposure in each stratum using the derivative of the fractional
polynomial function as themodel relating the LACE estimates
to the exposure values. The original fractional polynomial
function then represents the exposure-outcome relationship.
As this function is constructed from the LACE estimates, the
intercept of the exposure-outcome curve cannot be estimated
and must be set arbitrarily. If it is set to 0 at a reference value
(for instance, the mean of the exposure distribution), then the
value of the function represents the expected diﬀerence in the
outcome compared with this reference value when the expo-
sure is set to diﬀerent values.
Conﬁdence intervals (CIs) for the exposure-outcome curve
can be computed arithmetically under a normal assumption
either using the estimated standard errors from the metare-
gression or by bootstrapping the second and third steps from
above (we maintain the strata and estimate of the IV on the
exposure as in the original data, and estimate the associations
of the IV with the outcome in bootstrapped samples for each
stratum).
To explore a range of possible parametric forms, we ﬁt
all possible fractional polynomial models of degrees 1 and
2, and select the best-ﬁtting one based on the likelihood. A
fractional polynomial of degree 2 is preferred over one of
degree 1 if the twice the diﬀerence in the log-likelihood is
greater than the 95th percentile point of a 𝜒22 distribution for
the best-ﬁtting fractional polynomial in each class (Royston
& Altman, 1994).
2.3 Piecewise linear method
Another way of estimating the exposure-outcome relationship
is to use a piecewise linear approach. The exposure-outcome
relationship is estimated as piecewise linear function with
each stratum contributing a line segment whose gradient is the
LACE estimate for that stratum. The function is constrained
to be continuous, so that each line segment begins where
the previous segment ﬁnished. As in the fractional polyno-
mial method, although the intercept for each line segment is
ﬁxed by the previous line segment, the overall intercept of the
exposure-outcome curve cannot be estimated and must be set
arbitrarily.
CIs are estimated by bootstrapping the IV associations
with the outcome as in the fractional polynomial approach.
For a 95% CI, the piecewise linear method is performed
for each bootstrapped dataset, and then the 2.5th and 97.5th
percentiles of the function are taken at selected points across
the exposure distribution; we chose the mean exposure values
in each of the strata.
2.4 Tests of nonlinearity
There are already two proposed methods in this framework
for testing whether a nonlinear exposure-outcome model ﬁts
the data better than a linear model. The ﬁrst is a hetero-
geneity test using Cochran’s Q statistic to assess whether
the LACE estimates diﬀer more than would be expected by
chance. The second is a trend test where the LACE estimates
are metaregressed against the mean value of the exposure in
each strata; this is equivalent to ﬁtting a quadratic exposure-
outcome model.
A more ﬂexible version of this method is to test the best-
ﬁtting fractional polynomial of degree 1 against the linear
model. This can be achieved by comparing twice the dif-
ference in the log-likelihood between the linear model and
the best-ﬁtting fractional polynomial of degree 1 with a 𝜒21
distribution.
These methods are available in the nlmr R package
(https://github.com/jrs95/nlmr).
3 SIMULATION STUDY
To assess the performance of these methods in realistic sce-
narios for Mendelian randomization, we performed a simula-
tion study. We simulated data for 10,000 individuals for an IV
𝐺, a continuous exposure 𝑋 that takes only positive values, a
continuous outcome 𝑌 , and a confounder 𝑈 (assumed to be
unmeasured). The data-generating model for individual 𝑖 is
𝑥𝑖 = 2 + 0.25𝑔𝑖 + 𝑢𝑖 + 𝜖𝑋𝑖
𝑦𝑖 = ℎ(𝑥𝑖) + 0.8𝑢𝑖 + 𝜖𝑌 𝑖,
where 𝑔𝑖 ∼ Bin(2, 0.3), 𝜖𝑋𝑖 ∼ Exp(1), 𝑢𝑖 ∼ Unif(0,1), 𝜖𝑌 𝑖 ∼
𝑁(0, 1), and ℎ(𝑥𝑖) is the function relating the exposure to
the outcome (the exposure-outcome relationship). Exposure
values were taken to be positive and away from zero so
that the outcome takes sensible values for log and negative
power functions. The IV explains 2.6% of the variance in the
exposure.
3.1 Choice of exposure-outcome model
For the fractional polynomial method, all possible fractional
polynomials of degrees 1 and 2 were considered as the func-
tional form of the exposure-outcome relationship.
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Combinations of eﬀect sizes for the 𝛽 parameters were cho-
sen ranging from 0 to 2. For fractional polynomials of degree
2, we also considered eﬀects in opposing directions for 𝛽1
and 𝛽2; these simulations yielded similar results to those dis-
cussed here (results not shown). Fixed-eﬀects metaregression
was used in the simulations, however, random-eﬀects metare-
gression yielded similar results (results not shown).
For the piecewise linear method and comparisons between
methods, linear, quadratic, square-root, and logarithmic
functions were considered as the functional form of the
exposure-outcome relationship, as well as a threshold
model:
ℎ(𝑥𝑖) =
{
0 if 𝑥𝑖 ≤ 3.65
𝛽𝑥𝑖 if 𝑥𝑖 > 3.65.
3.2 Evaluating the performance of the
methods
To evaluate the fractional polynomial method, we ﬁrst ﬁtted
the correct fractional polynomial model (i.e., with the cor-
rect degree and powers) and assessed the bias and coverage
of the eﬀect parameter estimates. Subsequently, we ﬁtted all
fractional polynomials of the same degree and selected the
best-ﬁtting polynomial based on the likelihood. We assessed
the proportion of simulations where the best-ﬁtting fractional
polynomial was the correct fractional polynomial. If the cor-
rect fractional polynomial was not the best-ﬁtting fractional
polynomial, we tested whether it was in the group of fractional
polynomials that ﬁt the data almost as well as the best-ﬁtting
polynomial; deﬁned as those fractional polynomials where
twice the diﬀerence in the log-likelihood (compared with the
best-ﬁtting polynomial) was less than the 90th percentile point
of a 𝜒2
𝑚
distribution, where 𝑚 = 1 for comparing fractional
polynomials of degree 1 and 𝑚 = 2 for comparing polynomi-
als of degree 2.
To evaluate the piecewise linear method, we ﬁrst compared
the outcome estimates at the mean exposure value in each
quantile to the values of the true model at the same points.
The coverages of the bootstrapped 95% CIs were also evalu-
ated at these points.
For comparing the ﬁt of the fractional polynomial and
piecewise linear models, we used the following heuristic
function:
𝐾∑
𝑘=1
|| ̂̄𝑦𝑘 − ?̄?𝑘|| , (3)
where summation is across the 𝐾 quantile groups, and ?̄?𝑘 is
the expected value of the outcome evaluated at the mean value
of the exposure in each quantile group.
3.3 Varying the number of strata
In the initial simulations, the population was split based on
the IV-free exposure into decile groups. Further simulations
were performed varying the number of strata using 5, 10, 50,
and 100 quantile groups. Tests of nonlinearity were performed
to assess the impact of the number of strata on the empiri-
cal power of each test. The empirical power of each test was
reported as the proportion of simulation replicates with 𝑃 -
value less than 0.05. The heuristic function (3) was calculated
based on 10 deciles for each number of strata.
For each simulation and set of parameters, 500 replications
were performed. Bootstrap 95% CIs were generated using 500
bootstrap samples. All analyses were performed using R ver-
sion 3.0.2.
3.4 Additional simulations to assess impact of
violations of assumptions
We performed additional simulations in which the underly-
ing assumptions that the eﬀect of the IV on the exposure and
the eﬀect of the exposure on the outcome are ﬁxed and inde-
pendent were relaxed. In these simulations, we assessed both
modeling assumptions by allowing the eﬀect of the IV on the
exposure to vary (by drawing the eﬀect parameter from a nor-
mal distribution 𝑁(0.25, 0.12) for each individual in the pop-
ulation), and allowing the exposure-outcome relationship to
vary (by drawing the causal parameter from a normal distri-
bution 𝑁(𝛽, 0.22) for each individual in the population). We
assessed the impact of allowing each of these parameters to
vary separately and both to vary together. In addition, we also
allowed variation in both parameters to be correlated by draw-
ing the parameters from a bivariate normal distribution with
correlation 0.2. For fractional polynomials of degree 2, only
the causal parameter for the second polynomial was allowed
to vary across individuals.
We also performed further simulations using a low-
frequency genetic variant having a large eﬀect on the exposure
(minor allele frequency = 0.03, linear eﬀect on the exposure
= 0.75), and using the original genetic variant but having a
superadditive (ﬁrst allele increases exposure by 0.1 units, sec-
ond by 0.3 units) and a subadditive (ﬁrst allele increases expo-
sure by 0.3 units, second by 0.1 units) eﬀect on the exposure
in the data-generating model.
4 RESULTS
4.1 Fractional polynomial method
Comparisons of fractional polynomials for all powers are pro-
vided in Table S1 (degree 1) and Table S2 (degree 2); a sum-
mary of results for the most commonly encountered powers is
given in Table 1.
For fractional polynomials of degree 1, when ﬁtting the
correct fractional polynomial model, the causal estimate was
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TABLE 1 Simulation results for the fractional polynomial method
(a) Degree 1
Fitting correct FP Fitting all FPs
𝒑 𝜷 Mean (SD) [Mean SE] Coverage Powers
𝒑𝟏 𝜷𝟏 𝜷𝟏 𝜷𝟏 Correct Set
0 0 −0.01 (0.22) [0.21] 0.934 - -
0 1 0.98 (0.22) [0.21] 0.944 0.172 0.918
0 2 1.98 (0.21) [0.21] 0.954 0.386 0.910
0.5 0 0.00 (0.25) [0.23] 0.930 - -
0.5 1 1.00 (0.25) [0.23] 0.936 0.194 0.892
0.5 2 1.99 (0.24) [0.24] 0.932 0.340 0.904
1 0 0.00 (0.06) [0.06] 0.938 - -
1 1 1.00 (0.07) [0.07] 0.944 0.748 0.938
1 2 2.00 (0.07) [0.07] 0.938 0.912 0.958
2 0 0.00 (0.01) [0.01] 0.942 - -
2 1 1.02 (0.01) [0.01] 0.756 1.000 1.000
2 2 2.03 (0.02) [0.02] 0.436 1.000 1.000
(b) Degree 2
Fitting correct FP Fitting all FPs
𝒑 𝜷 Mean (SD) [Mean SE] Coverage Powers
𝒑𝟏 𝒑𝟐 𝜷𝟏 𝜷𝟐 𝜷𝟏 𝜷𝟐 𝜷𝟏 𝜷𝟐 Correct Set
0 0.5 0 0 −0.04 (1.98) [1.95] 0.06 (2.20) [2.17] 0.958 0.960 - -
0 0.5 1 2 1.00 (2.11) [2.03] 1.98 (2.35) [2.26] 0.938 0.934 0.004 0.964
0 0.5 2 1 1.95 (1.99) [2.02] 1.02 (2.23) [2.24] 0.952 0.956 0.002 0.968
0 1 0 0 −0.01 (0.95) [0.94] 0.00 (0.28) [0.28] 0.950 0.956 - -
0 1 1 2 1.00 (1.15) [1.17] 2.00 (0.35) [0.36] 0.940 0.940 0.012 0.948
0 1 2 1 2.03 (1.09) [1.08] 0.98 (0.33) [0.33] 0.938 0.938 0.016 0.956
0 2 0 0 −0.01 (0.48) [0.45] 0.00 (0.02) [0.02] 0.940 0.936 - -
0 2 1 2 1.30 (1.25) [1.09] 2.02 (0.06) [0.06] 0.898 0.902 0.026 0.954
0 2 2 1 2.12 (0.84) [0.81] 1.01 (0.04) [0.04] 0.938 0.926 0.040 0.964
0.5 1 0 0 −0.05 (2.06) [1.96] 0.01 (0.55) [0.53] 0.938 0.944 - -
0.5 1 1 2 1.03 (2.60) [2.56] 2.00 (0.72) [0.71] 0.940 0.938 0.010 0.954
0.5 1 2 1 1.86 (2.27) [2.34] 1.03 (0.62) [0.60] 0.950 0.950 0.006 0.960
0.5 2 0 0 −0.06 (0.65) [0.63] 0.00 (0.02) [0.02] 0.928 0.946 - -
0.5 2 1 2 1.48 (1.78) [1.63] 2.01 (0.08) [0.07] 0.936 0.934 0.024 0.970
0.5 2 2 1 2.18 (1.25) [1.19] 1.01 (0.05) [0.05] 0.924 0.936 0.036 0.948
1 2 0 0 0.01 (0.24) [0.24] 0.00 (0.03) [0.03] 0.952 0.954 - -
1 2 1 2 1.23 (0.78) [0.70] 2.00 (0.12) [0.11] 0.912 0.908 0.030 0.960
1 2 2 1 2.08 (0.57) [0.54] 1.00 (0.09) [0.08] 0.942 0.926 0.108 0.962
Notes. Results for all the fractional polynomials of degree 1 (all eﬀect sizes) and degree 2 (𝛽1=1 and 𝛽2=2) are presented in Tables S1 and S2; this table is a summary of
results for the most commonly encountered powers. 𝑝 are the powers and 𝛽 are the eﬀect parameters. Coverage refers to the number of replications where the true value
of 𝛽 was contained within the corresponding 95% CI. The power(s) was correctly chosen (Correct) if the best-ﬁtting fractional polynomial was also the correct fractional
polynomial, whil the correct model was within the set of powers that ﬁt the data equally, as well as the best-ﬁtting fractional polynomial (Set) if the diﬀerence between
twice the log-likelihood for the correct model and the best-ﬁtting model was less than the 90th percentile of the relevant 𝜒2 distribution. SD, standard deviation; SE,
standard error; FP, fractional polynomial; CI, conﬁdence interval.
generally unbiased (Table 1). Coverage estimates were close
to the nominal 95% rate, except for fractional polynomials
of power 2 (and power 3; Table S1), where causal estimates
were slightly biased, and this small bias led to undercover-
age. However, under the null, causal estimates were unbiased
and correct coverage rates were maintained. For fractional
polynomials of degree 2, a similar pattern was observed
except that small biases and resulting undercoveragewasmore
common, although correct coverage rate under the null was
always maintained.
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TABLE 2 Simulation results for the piecewise linear method
Decile of the IV-free exposure distribution Heuristic
Model 𝜷 Parameter 1 2 3 4 5 6 7 8 9 10 FP PL
Linear 0.5 Correct 0.201 0.357 0.460 0.550 0.641 0.743 0.870 1.040 1.302 1.995
Mean 0.197 0.352 0.454 0.543 0.633 0.736 0.862 1.032 1.296 1.961 1.12 1.20
Coverage 0.958 0.964 0.962 0.962 0.958 0.952 0.940 0.944 0.950 0.952 (0.74) (0.68)
Quadratic 0.5 Correct 0.891 1.697 2.281 2.826 3.409 4.107 5.027 6.360 8.644 16.002
Mean 1.011 1.831 2.426 2.982 3.572 4.281 5.214 6.568 8.891 16.617 1.07 2.94
Coverage 0.680 0.784 0.786 0.786 0.772 0.758 0.764 0.762 0.750 0.922 (0.77) (1.43)
Threshold 0.5 Correct 0.000 0.000 0.000 0.000 0.000 0.000 0.054 0.224 0.486 1.179
Mean 0.001 0.000 0.001 0.003 0.005 0.020 0.088 0.239 0.499 1.171 1.35 1.25
Coverage 0.960 0.964 0.952 0.950 0.942 0.930 0.934 0.930 0.940 0.946 (0.46) (0.73)
Threshold 1 Correct 0.000 0.000 0.000 0.000 0.000 0.000 0.108 0.448 0.971 2.359
Mean 0.008 0.012 0.013 0.012 0.014 0.041 0.181 0.493 1.017 2.393 2.31 1.33
Coverage 0.946 0.940 0.936 0.922 0.916 0.904 0.904 0.916 0.916 0.958 (0.42) (0.79)
Notes. 𝛽 is the eﬀect parameter. Mean is the mean value of the outcome at the mean value of the exposure in the deciles of the IV-free distribution. Coverage refers to
the number of replications where the correct value of the outcome at the mean value of the exposure in the decile of the IV-free distribution was contained within the
corresponding 95% prediction interval. The heuristic statistic (mean (SD) across simulations) is the sum of the absolute values of the predicted value of the outcome minus
the correct value of the outcome at the mean value of the exposure in deciles of the IV-free distribution. FP, fractional polynomial; PL, piecewise linear; IV, instrumental
variable.
When ﬁtting all the fractional polynomial models, the cor-
rect fractional polynomial model was ﬁtted more often for a
fractional polynomial of degree 1, and when the power of the
fractional polynomial diﬀered substantially from 0. Although
the power to detect the correct functional form was low for
the logarithmic and square-root functions, this is to some
extent an artifact of the choice of powers; if a basis with only
one concave function (either a logarithmic or a square-root
function) were used, then the correct model would be chosen
more often. As the causal parameter in the model increased,
the correct model was chosen more frequently. However, in all
cases, the correct fractional polynomial was in the set of best-
ﬁtting fractional polynomials in at least 89% of simulations.
The fractional polynomial test for nonlinearity rejects the null
exactly when the linear model is not in the set of best-ﬁtting
fractional polynomials. With a null causal eﬀect (𝛽 = 0), the
probability of ﬁtting the “correct” fractional polynomial was
not estimated as all fractional polynomials with zero coeﬃ-
cients would describe the data equally well. In reality, the true
exposure-outcome relationship is unlikely to have an exact
functional form, so the ability to estimate the shape of the rela-
tionship is more important that the precise identiﬁcation of the
function.
4.2 Piecewise linear method
The piecewise linear method performed well when the true
model was piecewise linear (such as a linear or a threshold
relationship), with the predicted mean values of the outcome
similar to their true values at the mean value of the exposure
within each decile of the IV-free exposure (Table 2). The
bootstrapped CIs also had approximately 95% coverage at
these points, except for the quantiles at or either side of the
point of inﬂection of the threshold model. However, when
the true model was not piecewise linear (in particular, for a
quadratic relationship), estimates were biased and coverage
was below nominal levels.
Using the heuristic function (3) to compare between the
estimates for the best-ﬁtting fractional polynomial and the
piecewise linear model, the models performed similarly
under a linear model. For a quadratic model, the fractional
polynomial method outperformed the piecewise linear
method, whereas the opposite was true for a threshold model.
This is unsurprising, as the fractional polynomial method
performed best when the true model was a polynomial, and
likewise for the piecewise linear method when the model was
piecewise linear.
4.3 Varying the number of strata
The best-ﬁtting fractional polynomial method had a simi-
lar or slightly better model ﬁt (judged by the heuristic func-
tion) when a greater number of strata were used (Table 3).
However, the piecewise linear method ﬁtted the data better
when fewer strata were used. Although the fractional poly-
nomial method ensures that the estimate of the exposure-
outcome relationship is a smooth function regardless of the
number of strata, the estimate from the piecewise linear
method becomes increasingly jagged as the number of strata
increases.
The coverage under the null (i.e., a linear model) was
not overly inﬂated for any of the tests. In general, the
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TABLE 3 Varying the number of strata and tests of nonlinearity
Heuristic Power of test
Model 𝜷
Number
of strata FP method PL method Quad Q FP test
Linear 1 5 1.18 (0.88) 1.24 (0.70) 0.076 0.054 0.050
10 1.11 (0.86) 1.30 (0.76) 0.074 0.040 0.046
50 1.06 (0.84) 1.48 (0.93) 0.064 0.064 0.040
100 1.08 (0.85) 1.55 (0.97) 0.062 0.062 0.036
Logarithm 2 5 1.34 (0.79) 1.35 (0.76) 0.486 0.342 0.502
10 1.31 (0.79) 1.37 (0.78) 0.488 0.264 0.518
50 1.30 (0.80) 1.56 (0.91) 0.504 0.164 0.544
100 1.31 (0.80) 1.62 (0.96) 0.504 0.124 0.530
Square root 2 5 1.21 (0.80) 1.23 (0.73) 0.166 0.102 0.170
10 1.22 (0.80) 1.33 (0.78) 0.156 0.084 0.166
50 1.21 (0.78) 1.56 (0.91) 0.164 0.072 0.176
100 1.20 (0.77) 1.63 (0.96) 0.164 0.104 0.178
Quadratic 0.1 5 1.10 (0.77) 1.37 (0.74) 0.618 0.422 0.608
10 1.03 (0.76) 1.42 (0.77) 0.710 0.392 0.674
50 0.90 (0.74) 1.52 (0.82) 0.830 0.226 0.774
100 0.87 (0.72) 1.59 (0.88) 0.874 0.186 0.818
Threshold 0.5 5 1.37 (0.47) 1.20 (0.71) 0.868 0.816 0.804
10 1.35 (0.44) 1.28 (0.76) 0.862 0.698 0.778
50 1.36 (0.46) 1.48 (0.89) 0.864 0.364 0.758
100 1.38 (0.50) 1.58 (0.97) 0.862 0.284 0.742
Notes. 𝛽 is the eﬀect parameter. The heuristic statistic (mean (SD) across simulations) is the sum of the absolute values of the predicted value of the outcome minus the
correct value of the outcome at the mean value of the exposure in deciles of the IV-free distribution. The heuristic measure for the fractional polynomial model was from
the best-ﬁtting fractional polynomial for the threshold model. SD, standard deviation; SE, standard error; Quad, quadratic test for assessing nonlinearity; Q, Cochran Q
test; FP, fractional polynomial; PL, piecewise linear; IV, instrumental variable.
fractional polynomial and quadratic tests were more pow-
erful than the Cochran Q test across the simulations.
The power of the Cochran Q test also decreased as the
number of strata increased, whereas the power of the
other tests either remained the same or increased. The
quadratic test slightly outperformed the fractional polynomial
test when the true model was a quadratic or a threshold
model; the fractional polynomial test was slightly superior
when the true model was a logarithm or a square-root
model.
4.4 Additional simulations to assess impact of
violations of assumptions
In the simulations where we relaxed the assumptions that
the IV–exposure and the exposure-outcome eﬀects are the
same for all individuals, we found that the fractional poly-
nomial models of degree 1 and the piecewise linear method
both performed well in terms of bias and coverage (Tables
S3 and S4). The only concern was that tests of nonlinearity
had slightly inﬂated Type I error rates when the IV-exposure
and exposure-outcome eﬀects were varied in a correlated way;
Type I error rate inﬂation was not observed when the eﬀects
were varied either separately or independently.
In the simulations with a low-frequency genetic vari-
ant having a large eﬀect on the exposure (Tables S5 and
S6), there was some bias in estimates. This is likely to be
the result of weak instrument bias (Burgess & Thompson,
2011): with a low-frequency variant, the variation in instru-
ment strength between the strata is much larger, and so the
chances of weak instrument bias aﬀecting the results in spe-
ciﬁc strata are increased. However, nominal Type I error rates
for tests of nonlinearity were maintained. With a superad-
ditive or subadditive model for the genetic association with
the exposure (Tables S5 and S6), estimates of the causal
parameter in the fractional polynomial method were unbi-
ased, but the power to detect nonlinearity was somewhat
reduced. Estimates in the piecewise linearmethod for a thresh-
old exposure-outcome relationship were somewhat biased.
This ﬁnding is consistent with previous work on measure-
ment error in the independent variable: here, the IV-free
exposure is estimated with error resulting from misspeci-
ﬁcation of the genetic association with the exposure (see
Section 6).
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5 APPLICATION OF METHODS TO
THE RELATIONSHIP BETWEEN BMI
AND BLOOD PRESSURE IN UK
BIOBANK
We illustrate the methods proposed in this paper in an applied
example considering the shape of relationship between BMI
and blood pressure in the UK Biobank study. The obser-
vational relationship between BMI and blood pressure has
been investigated previously in a variety of contexts: pop-
ulations of lean individuals (Kaufman et al., 1997), Danish
adolescents (Nielsen & Andersen, 2003), and Iranian ado-
lescents (Hosseini et al., 2010). The relationship has been
demonstrated to be monotonically increasing, with inconclu-
sive evidence for or against nonlinearity due to limited sample
sizes.
UK Biobank is a prospective cohort study of 502,682
participants recruited at 22 assessment centers across the
United Kingdom between 2006 and 2010 (Sudlow et al.,
2015). Participants were aged between 40 and 69 at baseline.
Extensive health, lifestyle, biological, and genetic mea-
surements were taken on all participants. At the time of
writing this paper, genetic information was only available for
133,687 individuals of European ancestry. For individuals
on antihypertensive medication, 15/10 mmHg were added
to their SBP/DBP (where SBP is systolic blood pressure and
DBP is diastolic blood pressure) measurement, respectively.
A sensitivity analysis was performed in individuals who had
no history of hypertension.
To create an allele score (also called a genetic risk
score) of variants related to BMI to be used as an IV, we
extracted the 97 variants previously associated with BMI
at a genome-wide level of signiﬁcance by the GIANT con-
sortium (Locke et al., 2015). A proxy variant (rs751414;
𝑟2 = 0.99) was used instead of rs2033529, as this variant
was not available in UK Biobank; the linkage disequilib-
rium information was calculated using the European sam-
ples from 1000 Genomes (Abecasis et al., 2012). All of
the variants were either directly genotyped or well-imputed
(INFO > 0.9). The allele score for each individual was com-
puted by multiplying the number of BMI-increasing alle-
les for each variant by the eﬀect of the variant on BMI (as
estimated in the GIANT consortium) and summing across
the 97 variants (Burgess & Thompson, 2013). Overall, this
score explained 1.7% of the variance in BMI. We per-
formed both fractional polynomial and piecewise linear meth-
ods for estimating the relationships of BMI with SBP and
DBP. The fractional polynomial method was implemented
using 100 strata, whereas the piecewise linear method was
implemented using 10 strata to avoid the exposure-outcome
curve being overly jagged. The reference point was set at
25 kg/m2.
To account for the multiple centers, we standardized the
measure of BMI by stratifying individuals based on their
residual value of BMI (the IV-free exposure) after regression
of BMI on the allele score, age, sex, and center (as a cat-
egorical variable). Adjustment for age, sex, and center was
also made in the regressions to obtain the LACE estimates
in each quantile group. If additional population stratiﬁcation
were expected, we could additionally adjust for genetic prin-
cipal components to minimize the eﬀect of population strati-
ﬁcation in biasing IV estimates.
To assess the assumption that the eﬀect of the IV on BMI
is constant over the entire distribution of BMI, we also con-
sidered BMI as the outcome and calculated the associations
of the IV with BMI in each of the strata. We then conducted
tests (trend and Cochran Q tests) to investigate heterogeneity
in the IV associations with BMI in diﬀerent strata.
5.1 Results of applied example
The exposure-outcome relationships for BMI with SBP and
DBP estimated using the fractional polynomial and piece-
wise linear methods are presented in Figure 1. There were
strong causal eﬀects of BMI on both SBP and DBP (𝑃 -value
< 1 × 10−5 for the causal estimates diﬀering from zero in the
fractional polynomial methods). For comparison, the standard
two-stage least squares linear estimate was 0.527 mmHg per
1 kg/m2 increase in BMI (95% CI: 0.363, 0.691) for SBP and
0.433 mmHg (95% CI: 0.338, 0.528) for DBP.
There was strong evidence that the association between
BMI and SBP was nonlinear, with the quadratic test yield-
ing a 𝑃 -value of 0.0026 (fractional polynomial test 𝑃 -value
= 0.0164, Cochran Q test 𝑃 -value = 0.0346). The best-ﬁtting
fractional polynomial of degree 1 for the relationship between
BMI and SBP had power −0.5, and there was no evidence
to suggest that a fractional polynomial of degree 2 ﬁtted the
data better (𝑃 -value = 0.135). The estimate of the exposure-
outcome relationship from the piecewise linear method visu-
ally suggested a threshold–type relationship, with a steep
slope up to a BMI value of about 32 kg/m2, and a slightly neg-
ative slope from 32 kg/m2 onwards. The relationship between
BMI and SBP was similar in individuals with no history of
hypertension (Fig. S1).
The association between BMI and DBP was also nonlin-
ear (quadratic test 𝑃 -value = 0.0005, fractional polynomial
test 𝑃 -value = 0.0114, Cochran Q test 𝑃 -value = 0.0049),
and there was strong evidence that the best-ﬁtting fractional
polynomial of degree 2 (with 𝑝1 and 𝑝2 = 3) ﬁtted the data
better than the best-ﬁtting fractional polynomial of degree 1
(𝑃 -value= 0.0062). There was no evidence of a diﬀerent rela-
tionship between BMI and DBP for underweight individu-
als, with the exposure-outcome curve increasing almost lin-
early up to a BMI of around 40 kg/m2. But for hyperobese
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F IGURE 1 Causal eﬀects of body mass index (BMI) on blood pressure (systolic blood pressure, SBP; diastolic blood pressure, DBP) using
the fractional polynomial and piecewise linear methods on data from UK Biobank: (a) SBP (fractional polynomial method), (b) DBP (fractional
polynomial method), (c) SBP (piecewise linear method), and (d) DBP (piecewise linear method). The red point represents the reference point of BMI
of 25 kg/m2. Gray lines represent 95% CIs. The fractional polynomial method used 100 strata.
individuals (BMI > 40 kg/m2), DBP seemed to decrease
sharply. This was particularly evident in the fractional polyno-
mial method, which used a greater number of strata and hence
had more resolution to consider the shape of the exposure-
outcome relationship at the extremes of the BMI distribu-
tion. One potential reason for this ﬁnding is that hyperobese
individuals with high DBP are less likely to be enrolled
in UK Biobank, perhaps due to diﬀerential survival prob-
ability. Another reason could be the diﬃculties in estimat-
ing blood pressure in hyperobese individuals (Leblanc et al.,
2013). However, there was no evidence that the relation-
ship between BMI and DBP was nonlinear in individuals
with no history of hypertension (𝑃 -value >0.05 for all tests;
Fig. S1).
There was no evidence that the associations of the IV with
BMI varied between the diﬀerent strata (trend test 𝑃 -value =
0.135, Cochran Q test 𝑃 -value = 0.901).
6 DISCUSSION
In this paper, we have proposed and tested two novel meth-
ods for examining the relationship between an exposure and
an outcome using IV analysis in the context of Mendelian
randomization. Both methods rely on stratifying the popula-
tion based on the IV-free exposure; the exposure minus the
eﬀect of the IV. A causal eﬀect, referred to as a LACE, is
estimated in each stratum of population. The ﬁrst method per-
forms metaregression on these LACE estimates using frac-
tional polynomials. The second method estimates a continu-
ous piecewise linear function, the gradient of which in each
stratum is the LACE estimate for that stratum. Both methods
were demonstrated in a simulation study to estimate the true
exposure-outcome relationship well when its functional form
corresponded to the form of the estimate from each method
(i.e., when the exposure-outcome relationship was a fractional
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polynomial for the fractional polynomial method, and when
the relationship was piecewise linear for the piecewise lin-
ear method), with causal estimates being close to unbiased
and coverage rates generally maintaining nominal levels (in
particular, coverage rates were always correct under the null).
Additionally, tests of nonlinearity were provided and their per-
formance was assessed. The quadratic and fractional polyno-
mial tests had the best performance in terms of Type I error
rate and power.
6.1 Comparison of methods
The recommendation as to which method to use depends
on the aim of the investigation. The fractional polyno-
mial method will always provide a smooth estimate of the
exposure-outcome relationship, and as such has more consis-
tent performance when a large number of strata are chosen
(i.e., when the shape of the relationship is considered over a
wider and more detailed range of the exposure distribution).
Fractional polynomials of degree 1 had better performance
than those of degree 2 in terms of bias and coverage of
eﬀect estimates. However, fractional polynomials of degree
1 are less ﬂexible and would not be able to model complex
exposure-outcome relationships. Additionally, they tend
to smooth over discrepancies in the data. For example, if
the LACE estimate for individuals in the lowest quantile
group for BMI was substantially diﬀerent to the other LACE
estimates, then both this diﬀerence and any uncertainty in
the LACE estimate would be smoothed over somewhat in
the fractional polynomial estimate. Preference between the
methods therefore comes down to a question of prior belief:
if one truly believes the true exposure-outcome relationship
to be smooth, and that estimates in the surrounding quantiles
should be used to model the LACE in the target quantile,
then the fractional polynomial method should be preferred.
However, if one does not want to smooth over estimates, then
the piecewise linear method should be preferred; however,
the estimate of the exposure-outcome relationship will be
more jagged and variable.
The number of strata and divisions between strata should
ideally be speciﬁed before the analysis according to practi-
cal considerations (e.g., previously determined categories of
BMI) and the sample size available. If the number of strata is
too large, then each stratum will have a small sample size. The
LACE estimate in a small stratum will be imprecise and may
be susceptible to weak instrument bias (Burgess&Thompson,
2011), particularly if the genetic variant is rare.
6.2 Interpretation of the exposure-outcome
relationship
If the function relating the exposure to the average value of
the outcome is homogeneous across the population, then the
methods provided in this paper estimate this function (the
exposure-outcome relationship) even if there is unmeasured
confounding. If the function is heterogeneous, then the
situation is more complicated (Small, 2014). For example,
taking BMI as the exposure, if the subject-speciﬁc eﬀect
curve (as deﬁned by Small, 2014) is linear for all individuals
in the population, but the magnitude of eﬀect is greater for
overweight individuals, then the exposure-outcome relation-
ship will be quadratic (or at least convex and positive) rather
than linear. The exposure-outcome curve at low values of the
exposure is only estimated using underweight individuals,
and at high values of the exposure only using overweight
individuals. However, this is perhaps the most relevant way
to express the exposure-outcome relationship, as the causal
eﬀect of reducing one’s BMI from 20 to 18 kg/m2 is not so
relevant for someone with a BMI of 40 kg/m2. Hence, we do
not claim any global interpretation of the exposure-outcome
relationship as estimated in this paper apart from in the
unlikely case that the functional relationship is homogeneous
in the population. It is better interpreted as a series of local
estimates, which are graphically connected in order to com-
pare and contrast trends in these local estimates at diﬀerent
values of the exposure, and to compare the relative beneﬁt
of intervening on the exposure for individuals with diﬀerent
values of the exposure, but which does not necessarily reﬂect
the eﬀect of intervening on the exposure to take any value in
its distribution for any single individual.
6.3 Measurement error in the exposure
As has been noted in other contexts, estimates of nonlin-
ear relationships are sensitive to measurement error in the
exposure (Keogh, Strawbridge, & White, 2012). The stan-
dard “triple whammy” of measurement error is likely to
apply here: measurement error biases parameter estimates,
reduces power, and obscures important features in the shape
of relationships (Carroll, Ruppert, Stefanski, & Crainiceanu,
2006). For example, with a threshold relationship, measure-
ment error in the exposure would mean that the point of
inﬂexion in the exposure-outcome relationship would be less
sharply evident. In the case of BMI, measurement error is not
such an issue, as height and weight can be measured precisely,
and neither variable experiences substantial diurnal or sea-
sonal variation. However, for other exposures, measurement
error may aﬀect results more severely. As noted in the addi-
tional simulation analyses, bias due to measurement error can
also occur if the model for the genetic association with the
exposure is misspeciﬁed.
6.4 Requirement of concomitant and
individual-level data
Many recent advances in Mendelian randomization have
enabled investigations to be performed using summarized
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data on the genetic associations with the exposure and with
the outcome only, and/or in a two-sample setting in which
genetic associations with the exposure and with the outcome
are estimated on separate groups of individuals (Burgess, But-
terworth, & Thompson, 2013; Burgess et al., 2015). However,
estimation of the exposure-outcome relationship requires both
individual-level data and a one-sample setting (otherwise nei-
ther stratiﬁcation of the population nor the estimation of
genetic associations with the outcome in the strata is possi-
ble). Although large cohorts with concomitant data on genetic
variants, exposures, and outcomes are becoming more widely
available, particularly in the form of biobanks such as UK
Biobank.
In conclusion, these two novel methods are useful in inves-
tigating nonlinear exposure-outcome relationships. The meth-
ods allow for easy graphical assessment of the shape of the
relationship, and allied with tests of nonlinearity, provide an
eﬀective tool for assessing nonlinear exposure-outcome rela-
tionships using IV analysis for Mendelian randomization.
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